课题基金 / 基金详情

Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis

Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis
使用动态对比增强磁共振成像 (DCE-MRI) 建立下颌放射性骨坏死的客观临床结果测量
批准号:
10086515
负责人:
STEPHEN Y LAI
金额:
$3.32万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2022-03-31
关键词:
3-DimensionalAcuteAlgorithmsAntibioticsBlood VesselsCancer PatientCaringChronicClinicalClinical ResearchComplexComplicationContrast MediaCoupledDataData ReportingDebridementDevelopmentDiagnosisDiagnostic ImagingDisease ManagementDisease ProgressionDrug KineticsEffectivenessEnsureEpidemicEpidemiologyEventExcisionExternal Beam Radiation TherapyFailureGoalsHead and Neck CancerHead and Neck NeoplasmsHead and neck structureHumanHuman PapillomavirusHyperbaric OxygenImageImpaired healingIncidenceInfectionInjectionsInstitutionIntensity-Modulated RadiotherapyKnowledgeLeadLife ExpectancyMagnetic Resonance ImagingMandibleMapsMeasurementMeasuresMethodsMissionMonitorMorbidity - disease rateNatural HistoryNecrosisOperative Surgical ProceduresOpportunistic InfectionsOral cavityOropharyngeal NeoplasmsOsteoradionecrosisOutcomeOutcome MeasurePathologicPatient Outcomes AssessmentsPatientsPerfusionPhysiologyPopulations at RiskPostoperative PeriodProcessPublic HealthRadiation Dose UnitRadiation exposureRadiation therapyReportingResidual stateResolutionResourcesRiskSEER ProgramSeriesSignal TransductionSolid NeoplasmStagingStaging SystemStandardizationSurgical FlapsSurgical ManagementSystemTechniquesTestingTimeTissuesUnited StatesUnited States National Institutes of HealthVascular remodelingWorkX-Ray Computed Tomographybasebonebone healingbone healthcancer therapycohortcontrast enhanceddensityhealingimaging modalityimpressionimprovedirradiationlifetime riskmortalitymultimodalitypatient populationprospectivepublic health relevancequantitative imagingreconstructionresponsesuccesstreatment responsetumor growthwound care

项目摘要

项目成果

STEPHEN Y LAI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Changes in the epidemiology of head and neck cancers have resulted in an increasing number of younger and healthier patients being treated with definitive external beam radiotherapy (EBRT). The long-term sequelae of radiotherapy in a patient population with good clinical outcomes and extended life expectancy are becoming increasingly relevant in the management of treatment-associated morbidity and mortality. Osteoradionecrosis (ORN) of the mandible is a challenging issue related to irradiation, occurring in up to 16% of patients with various types of head and neck cancers. Altered bone vascularity and opportunistic infections within the oral cavity contribute to the development of ORN, leading to an inexorable process of bone destruction that does not follow the normal sequence of healing events. Early-stage ORN is often managed using antibiotics, local wound care, and hyperbaric oxygen (HBO). Advanced ORN requires surgical resection and reconstruction with healthy non-irradiated tissue. Successful management of this disease process requires an enhanced ability to identify patients at risk for ORN, monitor the effectiveness of conservative management, and improve preoperative planning to ensure clear margins at the time of resection. However, a standardized, objective staging and monitoring system for ORN is not currently available. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a clinically available quantitative imaging method that is increasingly employed to assess microvascular function in the study of solid tumors of the head and neck. At our institution, DCE-MRI is integrated into a multimodality clinical algorithm aimed at improving the diagnosis, staging, and oncologic surveillance of head and neck tumors. DCE-MRI can detect altered bone vascularity associated with bone healing, necrosis and metastatic involvement, with excellent spatial resolution. We hypothesize that DCE-MRI can be used to detect alterations in bone vascularity following irradiation to monitor ORN clinical progression and response to treatment. To test this hypothesis, we will evaluate the potential of DCE-MRI to identify patients at risk for mandibular ORN, monitor response to conservative management, and determine the extent of advanced mandibular ORN to assist in surgical planning. Successful completion of this proposal has the potential to revolutionize the diagnosis and management of mandibular ORN. For the first time, clinicians will be able to identify patients at risk for ORN and manage post-radiotherapy care appropriately. The effectiveness of currently employed conservative measures could be tested using an objective measure and improved preoperative planning could reduce the rate of surgical failure due to residual compromised bone.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
In Regard to Wallner et al.
关于沃尔纳等人。
DOI: 10.1016/j.ijrobp.2019.10.044
发表时间: 2020
期刊: International journal of radiation oncology, biology, physics
影响因子: --
作者: [Kang,John, Thompson,ReidF, Fuller,CliftonD, Camphausen,KevinA, Gabriel,PeterE, Thomas,CharlesR]
通讯作者: Thomas,CharlesR
Osteoradionecrosis in patients with salivary gland malignancies.
唾液腺恶性肿瘤患者的放射性骨坏死。
DOI: 10.1016/j.oraloncology.2016.03.006
发表时间: 2016
期刊: Oral oncology
影响因子: 4.8
作者: [Tucker,JRhet, Xu,Li, Sturgis,ErichM, Mohamed,AbdallahSR, Hofstede,TheresaM, Chambers,MarkS, Lai,StephenY, Fuller,CliftonDavid, Beadle,Beth, Gunn,GBrandon, Hutcheson,KatherineA]
通讯作者: Hutcheson,KatherineA
DOI: 10.1002/hed.27024
发表时间: 2022-06
期刊: Head & neck
影响因子: --
作者: []
通讯作者:
Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers.
头颈癌患者低镁血症和放射性骨坏死的发生率。
DOI: 10.1002/hed.26510
发表时间: 2021-02
期刊: Head & neck
影响因子: --
作者: []
通讯作者:
Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma
Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers
Quantification of cisplatin sensitivity and resistance using metabolic imaging and circulating tumor cell (CTC) biomarkers
Radiosensitization of thyroid cancer by cancer cell specific reduction of gold ions
海外基金